The invention relates to the use of a branched polyester having an average of at least 2.8 terminal groups as additive for a curable pre-polymer composition, wherein the branched polyester acts as de-foaming agent.

The invention relates to the use of a branched polyester having an average of at least 2.8 terminal groups as additive for a curable pre-polymer composition, wherein the branched polyester acts as de-foaming agent.

Embodiments relate to a one-component type paint composition with superior scratch resistance and secures excellent scratch restoring performance by including a resin, a curing agent, a curing catalyst and an organic solvent, whereby the resin includes: 30 to 70 wt % of a carbamate group-containing acrylic polyol resin; and 5 to 25 wt % of a hyperbranched structure carbamate group-containing polyester polyol resin, based on 100 wt % of the paint composition.

Embodiments relate to a one-component type paint composition with superior scratch resistance and secures excellent scratch restoring performance by including a resin, a curing agent, a curing catalyst and an organic solvent, whereby the resin includes: 30 to 70 wt % of a carbamate group-containing acrylic polyol resin; and 5 to 25 wt % of a hyperbranched structure carbamate group-containing polyester polyol resin, based on 100 wt % of the paint composition.

The present invention discloses novel calibrants containing between 1 and 5 iodine atoms and methods of making them using linear polymers, hyperbranched polymers, and biological polymers (including but not limited to proteins and peptides.) Methods of using the calibrants are also disclosed, such as mass spectrometry. The novel calibrants disclosed herein have a more cost- and time-efficient synthesis than other calibrants.

The present disclosure relates to a formulation including: a) a dendron of Formula I; b) at least one bio-therapeutic; c) at least one buffer; and d) at least one salt, wherein the bio-therapeutic to dendron molar ratio is in the range of 1:0.5-1:3. The dendron stabilizes the bio-therapeutic in the formulation at a temperature of up to 55 C.

##STR00001##

The present disclosure relates to a formulation including: a) a dendron of Formula I; b) at least one bio-therapeutic; c) at least one buffer; and d) at least one salt, wherein the bio-therapeutic to dendron molar ratio is in the range of 1:0.5-1:3. The dendron stabilizes the bio-therapeutic in the formulation at a temperature of up to 55 C.

##STR00001##

A nanoglue is formed with one or more bioadhesive polymers, one or more dendrimers, and optionally one or more therapeutic, prophylactic, or diagnostic agents. The bioadhesive polymers and dendrimers are modified with functional groups to permit crosslinking upon one or more stimuli, e.g., ultraviolet irradiation, and form hydrogel in situ at tissue sites. In the repair of corneal wounds, the nanoglue leads to improved rate of healing with less scarring and less inflammation, compared to non-treated cornea or ones treated with sutures. Therapeutic agents can be covalently conjugated to the precursor components and be delivered to specific eye compartments, providing a more efficacious treatment formulation of ocular disorders than delivering drugs in their free forms. Methods of making and using the hydrogel and hydrogel precursor compositions are also provided.

A nanoglue is formed with one or more bioadhesive polymers, one or more dendrimers, and optionally one or more therapeutic, prophylactic, or diagnostic agents. The bioadhesive polymers and dendrimers are modified with functional groups to permit crosslinking upon one or more stimuli, e.g., ultraviolet irradiation, and form hydrogel in situ at tissue sites. In the repair of corneal wounds, the nanoglue leads to improved rate of healing with less scarring and less inflammation, compared to non-treated cornea or ones treated with sutures. Therapeutic agents can be covalently conjugated to the precursor components and be delivered to specific eye compartments, providing a more efficacious treatment formulation of ocular disorders than delivering drugs in their free forms. Methods of making and using the hydrogel and hydrogel precursor compositions are also provided.

In various exemplary embodiments described herein, an absorbent structure (e.g., a paper material) having an applied absorbent material (e.g., an absorbent film) may be formed by treating a fiber (e.g., a cellulosic fiber) with an applied absorbent material forming system (also referred to as a film forming system), absorbent materials, compositions, methods of making absorbent materials, and the like.